CKD Bio Corp. Logo

CKD Bio Corp.

Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.

063160 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 서대문구 충정로 8, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CKD Bio Corp. is a biopharmaceutical company specializing in the development and manufacturing of probiotics and active pharmaceutical ingredients (APIs). Leveraging over 50 years of expertise in fermentation technology and chemical synthesis, the company's core activities include the production of fermentation-based APIs, such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. It also focuses on the research and development of next-generation probiotics through its dedicated microbiome research division. Additionally, CKD Bio provides Contract Manufacturing Organization (CMO) services for APIs and intermediates, utilizing its cGMP-certified production facilities. The company manages a fully integrated process from microbial strain development and fermentation to purification and final synthesis, aiming for global leadership in biotechnology.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for CKD Bio Corp. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-17 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 7.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 912.4 KB

Automate Your Workflow. Get a real-time feed of all CKD Bio Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CKD Bio Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Sanofi Logo
Global biopharma firm researching, developing & marketing prescription medicines & vaccines.
France SAN
SANTEN PHARMACEUTICAL CO.,LTD. Logo
A global ophthalmology specialist developing drugs and devices for glaucoma, dry eye, and infections.
Japan 4536
Santhera Pharmaceuticals Holding AG Logo
Develops innovative medicines for rare neuromuscular and mitochondrial disorders.
Switzerland SANN
SAWAI GROUP HOLDINGS Co., Ltd. Logo
A leading Japanese generic drug maker expanding into digital health and wellness solutions.
Japan 4887
Scandion Oncology A/S Logo
Biotech company in liquidation, formerly developing therapies to overcome cancer drug resistance.
Denmark SCOL
Develops high-purity stem cell therapies for incurable immunological and inflammatory diseases.
South Korea 298060
Seach Medical Group Ltd. Logo
Researches, cultivates, and produces certified medical cannabis oils and flowers for global markets.
Israel SEMG
SEEGENE, INC. Logo
Develops multiplex qPCR diagnostic assays and automated systems for labs and healthcare worldwide.
South Korea 096530
SEIKAGAKU CORPORATION Logo
A research pharma company using glycoscience to develop drugs for orthopedic & ophthalmic diseases.
Japan 4548
SEOUL PHARMA CO.,LTD Logo
Develops pharmaceuticals with innovative Orally Disintegrating Film (ODF) tech for global markets.
South Korea 018680

Talk to a Data Expert

Have a question? We'll get back to you promptly.